Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie: Substanzspezifische Relevanz und aktuelle Handlungsempfehlungen

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • L. Klotz - (Author)
  • A. Berthele - (Author)
  • W. Brück - (Author)
  • A. Chan - (Author)
  • P. Flachenecker - (Author)
  • R. Gold - (Author)
  • A. Haghikia - (Author)
  • K. Hellwig - (Author)
  • B. Hemmer - (Author)
  • R. Hohlfeld - (Author)
  • T. Korn - (Author)
  • T. Kümpfel - (Author)
  • M. Lang - (Author)
  • V. Limmroth - (Author)
  • R.A. Linker - (Author)
  • U. Meier - (Author)
  • S.G. Meuth - (Author)
  • F. Paul - (Author)
  • A. Salmen - (Author)
  • M. Stangel - (Author)
  • B. Tackenberg - (Author)
  • H. Tumani - (Author)
  • C. Warnke - (Author)
  • M.S. Weber - (Author)
  • T. Ziemssen - , Department of Neurology (Author)
  • F. Zipp - (Author)
  • H. Wiendl - (Author)
Translated title of the contribution
Monitoring of blood parameters under course-modified MS therapy
Substance-specific relevance and current recommendations for action

Details

Original languageGerman
Pages (from-to)645–659
Number of pages15
JournalDer Nervenarzt
Volume87
Publication statusPublished - 2016
Peer-reviewedYes

External IDs

ORCID /0000-0001-8799-8202/work/43647695
Scopus 84959374860

Keywords